FUTURETECH II ACQUISITION CORP. - CLASS A COMMON S

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

04 ديسمبر 2024 12:35:00 بحسب Nasdaq GlobeNewswire

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

20 سبتمبر 2024 13:55:00 بحسب Nasdaq GlobeNewswire

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

17 مايو 2023 15:05:00 بحسب Nasdaq GlobeNewswire